Volume 14, 2023
|
|
Editorials
Severe herpesvirus infection beats adult T-cell leukemia/lymphoma
https://doi.org/10.18632/genesandcancer.228
Tatsuro Jo
p 1-2
Research Perspective
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
https://doi.org/10.18632/genesandcancer.229
Dalil Hannani, Estelle Leplus, Karine Laulagnier, Laurence Chaperot, and Joël Plumas
p 3-11
Reviews
CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens
https://doi.org/10.18632/genesandcancer.230
Jerin Thomas, Addison Klebanov, Sahara John, Larry S. Miller, Anil Vegesna, Richard L. Amdur, Krishanu Bhowmick, and Lopa Mishra
p 12-29
Research Papers
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer
https://doi.org/10.18632/genesandcancer.231
Ye S. Lee, Jennifer E. Klomp, Clint A. Stalnecker, Craig M. Goodwin, Yanzhe Gao, Gaith N. Droby, Cyrus Vaziri, Kirsten L. Bryant, Channing J. Der, and Adrienne D. Cox
p 30-49
Abstract | PDF | Full Text | Supplementary Materials | Supplementary Table 1
Research Papers
A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature
https://doi.org/10.18632/genesandcancer.232
Kmira Zahra, Wided Cherif, Gereisha Ahmed, Haifa Regaieg, Ben Sayed Nesrine, Monia Zaier, Wided Mootamri, Yosra Ben Youssef, Nejia Brahem, Halima Sennana, and Abderrahim Khelif
p 50-55
Research Papers
Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma
https://doi.org/10.18632/genesandcancer.233
Drumond-Bock Ana Luiza, Wang Luyao, Wang Lin, Cybula Magdalena, Rostworowska Maria, Kinter Michael, and Bieniasz Magdalena
p 56-76